Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
As part of its work, the Antibacterial Drug Development Task Force will assist in developing and revising guidance related to antibacterial drug development, as required by regulation signed into law earlier this year. The task force is comprised of 19 scientists and clinicians who will use existing partnerships and collaborations to work with other experts in the field.
More Articles on the FDA:
32 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in August
